S. Blot, P. Depuydt, K. Vandewoude, D. Bacquer, and D. , Measuring the impact of multidrug resistance in nosocomial infection, Current Opinion in Infectious Diseases, vol.20, issue.4, pp.391-396, 2007.
DOI : 10.1097/QCO.0b013e32818be6f7

I. Chopra, C. Schofield, M. Everett, A. Neill, K. Miller et al., Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement, The Lancet Infectious Diseases, vol.8, issue.2, pp.133-139, 2008.
DOI : 10.1016/S1473-3099(08)70018-5

M. E. Falagas and I. A. Bliziotis, Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?, International Journal of Antimicrobial Agents, vol.29, issue.6, pp.630-636, 2007.
DOI : 10.1016/j.ijantimicag.2006.12.012

T. N. Gandhi, D. D. Depestel, C. D. Collins, J. Nagel, and L. L. Washer, Managing antimicrobial resistance in intensive care units, Critical Care Medicine, vol.38, issue.8, pp.315-323, 2010.
DOI : 10.1097/CCM.0b013e3181e6a2a4

L. B. Rice, The clinical consequences of antimicrobial resistance, Current Opinion in Microbiology, vol.12, issue.5, pp.476-481, 2009.
DOI : 10.1016/j.mib.2009.08.001

H. Nikaido, Molecular Basis of Bacterial Outer Membrane Permeability Revisited, Microbiology and Molecular Biology Reviews, vol.67, issue.4, pp.593-656, 2003.
DOI : 10.1128/MMBR.67.4.593-656.2003

H. Nikaido, Multidrug Resistance in Bacteria, Annual Review of Biochemistry, vol.78, issue.1, pp.119-146, 2009.
DOI : 10.1146/annurev.biochem.78.082907.145923

J. Pagès, C. E. James, and M. Winterhalter, The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria, Nature Reviews Microbiology, vol.390, issue.12, pp.893-903, 2008.
DOI : 10.1016/S0969-2126(99)80055-0

M. N. Alekshun and S. B. Levy, Molecular Mechanisms of Antibacterial Multidrug Resistance, Cell, vol.128, issue.6, pp.1037-1050, 2007.
DOI : 10.1016/j.cell.2007.03.004

A. Davin-regli, J. M. Bolla, C. E. James, J. P. Lavigne, J. Chevalier et al., Membrane Permeability and Regulation of Drug “Influx and Efflux” in Enterobacterial Pathogens, Current Drug Targets, vol.9, issue.9, pp.750-759, 2008.
DOI : 10.2174/138945008785747824

X. Z. Li and H. Nikaido, Efflux-Mediated Drug Resistance in Bacteria, Drugs, vol.75, issue.5, pp.1555-1623, 2009.
DOI : 10.2165/11317030-000000000-00000

H. Nikaido, Structure and Mechanism of RND-Type Multidrug Efflux Pumps, Adv. Enzymol. Relat. Areas Mol. Biol, vol.25, pp.1-60, 2011.
DOI : 10.1002/9780470920541.ch1

L. J. Piddock, Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria, Clinical Microbiology Reviews, vol.19, issue.2, pp.382-402, 2006.
DOI : 10.1128/CMR.19.2.382-402.2006

K. Poole, Efflux pumps as antimicrobial resistance mechanisms, Annals of Medicine, vol.58, issue.1, pp.162-176, 2007.
DOI : 10.1093/jac/dkl441

T. Eicher, L. Brandstätter, and K. M. Pos, Structural and functional aspects of the multidrug efflux pump AcrB, Biological Chemistry, vol.390, issue.8, pp.693-699, 2009.
DOI : 10.1515/BC.2009.090

S. Murakami, Multidrug efflux transporter, AcrB???the pumping mechanism, Current Opinion in Structural Biology, vol.18, issue.4, pp.459-465, 2008.
DOI : 10.1016/j.sbi.2008.06.007

H. Nikaido and Y. Takatsuka, Mechanisms of RND multidrug efflux pumps, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, vol.1794, issue.5, pp.769-781, 2009.
DOI : 10.1016/j.bbapap.2008.10.004

S. Alibert-franco, B. Pradines, A. Mahamoud, A. Davin-regli, and J. Pagès, Efflux Mechanism, an Attractive Target to Combat Multidrug Resistant Plasmodium falciparum and Pseudomonas aeruginosa, Current Medicinal Chemistry, vol.16, issue.3, pp.301-317, 2009.
DOI : 10.2174/092986709787002619

K. M. Pos, Drug transport mechanism of the AcrB efflux pump, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, vol.1794, issue.5, pp.782-793, 2009.
DOI : 10.1016/j.bbapap.2008.12.015

X. Q. Yao, H. Kenzaki, S. Murakami, and S. Takada, Drug export and allosteric coupling in a multidrug transporter revealed by molecular simulations, Nature Communications, vol.81, issue.8, p.117, 2010.
DOI : 10.1038/ncomms1116

J. Pagès, S. Alibert-franco, A. Mahamoud, J. M. Bolla, A. Davin-regli et al., Efflux Pumps of Gram-Negative Bacteria, a New Target for New Molecules, Current Topics in Medicinal Chemistry, vol.10, issue.18, pp.1848-1857, 2010.
DOI : 10.2174/156802610793176620

R. Schulz and U. Kleinekathöfer, Transitions between Closed and Open Conformations of TolC: The Effects of Ions in Simulations, Biophysical Journal, vol.96, issue.8, pp.3116-3125, 2009.
DOI : 10.1016/j.bpj.2009.01.021

M. F. Symmons, E. Bokma, E. Koronakis, C. Hughes, and V. Koronakis, The assembled structure of a complete tripartite bacterial multidrug efflux pump, Proc. Natl. Acad. Sci. USA, pp.7173-7178, 2009.
DOI : 10.1073/pnas.0900693106

Y. Takatsuka, C. Chen, and H. Nikaido, Mechanism of recognition of compounds of diverse structures by the multidrug efflux pump AcrB of Escherichia coli, Proc. Natl. Acad. Sci. USA, pp.6559-6565, 2010.
DOI : 10.1073/pnas.1001460107

N. Tal and S. Schuldiner, A coordinated network of transporters with overlapping specificities provides a robust survival strategy, Proc. Natl. Acad. Sci. USA, pp.9051-9056, 2009.
DOI : 10.1073/pnas.0902400106

K. Bush and G. A. Jacoby, Updated Functional Classification of ??-Lactamases, Antimicrobial Agents and Chemotherapy, vol.54, issue.3, pp.969-976, 2010.
DOI : 10.1128/AAC.01009-09

K. Bush and M. J. Macielag, New ??-lactam antibiotics and ??-lactamase inhibitors, Expert Opinion on Therapeutic Patents, vol.65, issue.10, pp.1277-1293, 2010.
DOI : 10.1093/jac/dkn320

S. M. Drawz and R. A. Bonomo, Three Decades of ??-Lactamase Inhibitors, Clinical Microbiology Reviews, vol.23, issue.1, pp.160-201, 2010.
DOI : 10.1128/CMR.00037-09

J. G. Hurdle, A. J. Neill, I. Chopra, and R. E. Lee, Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections, Nature Reviews Microbiology, vol.20, issue.1, pp.62-75, 2011.
DOI : 10.1038/nrmicro2474

S. K. Vooturi and S. M. Firestine, Synthetic Membrane-Targeted Antibiotics, Current Medicinal Chemistry, vol.17, issue.21, pp.2292-2300, 2010.
DOI : 10.2174/092986710791331059

M. E. Falagas, P. I. Rafailidis, and D. K. Matthaiou, Resistance to polymyxins: Mechanisms, frequency and treatment options, Drug Resistance Updates, vol.13, issue.4-5, pp.132-138, 2010.
DOI : 10.1016/j.drup.2010.05.002

D. Landman, C. Georgescu, D. A. Martin, and J. Quale, Polymyxins Revisited, Clinical Microbiology Reviews, vol.21, issue.3, pp.449-465, 2008.
DOI : 10.1128/CMR.00006-08
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2493081

M. Vaara, Polymyxins and their novel derivatives, Current Opinion in Microbiology, vol.13, issue.5, pp.574-581, 2010.
DOI : 10.1016/j.mib.2010.09.002

T. Mogi and K. Kita, Gramicidin S and polymyxins: the revival of cationic cyclic peptide antibiotics, Cellular and Molecular Life Sciences, vol.41, issue.23, pp.3821-3826, 2009.
DOI : 10.1007/s00018-009-0129-9

R. L. Soon, T. Velkov, F. Chiu, P. E. Thompson, R. Kancharla et al., Design, synthesis, and evaluation of a new fluorescent probe for measuring polymyxin???lipopolysaccharide binding interactions, Analytical Biochemistry, vol.409, issue.2, pp.273-283, 2011.
DOI : 10.1016/j.ab.2010.10.033

H. Giamarellou and G. Poulakou, Multidrug-Resistant Gram-Negative Infections, Drugs, vol.46, issue.7, pp.1879-1901, 2009.
DOI : 10.2165/11315690-000000000-00000

R. L. Nation and J. Li, Colistin in the 21st century, Current Opinion in Infectious Diseases, vol.22, issue.6, pp.535-543, 2009.
DOI : 10.1097/QCO.0b013e328332e672

C. Urban, H. Tiruvury, N. Mariano, R. Colon-urban, and J. J. Rahal, Polymyxin-Resistant Clinical Isolates of Escherichia coli, Antimicrobial Agents and Chemotherapy, vol.55, issue.1, pp.388-389, 2011.
DOI : 10.1128/AAC.01088-10

G. A. Pankuch, G. Lin, H. Seifert, and P. C. Appelbaum, Activity of Meropenem with and without Ciprofloxacin and Colistin against Pseudomonas aeruginosa and Acinetobacter baumannii, Antimicrobial Agents and Chemotherapy, vol.52, issue.1, pp.333-336, 2008.
DOI : 10.1128/AAC.00689-07

R. M. Humphries, T. Kelesidis, D. Bard, J. Ward, K. W. Bhattacharya et al., Successful treatment of pan-resistant Klebsiella pneumoniae pneumonia and bacteraemia with a combination of high-dose tigecycline and colistin, Journal of Medical Microbiology, vol.59, issue.11, pp.1383-1386, 2010.
DOI : 10.1099/jmm.0.023010-0

N. Aoki, K. Tateda, Y. Kikuchi, S. Kimura, C. Miyazaki et al., Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa, Journal of Antimicrobial Chemotherapy, vol.63, issue.3, pp.534-542, 2009.
DOI : 10.1093/jac/dkn530

N. C. Gordon, K. Png, and D. W. Wareham, Potent Synergy and Sustained Bactericidal Activity of a Vancomycin-Colistin Combination versus Multidrug-Resistant Strains of Acinetobacter baumannii, Antimicrobial Agents and Chemotherapy, vol.54, issue.12, pp.5316-5322, 2010.
DOI : 10.1128/AAC.00922-10

C. Urban, N. Mariano, and J. J. Rahal, In Vitro Double and Triple Bactericidal Activities of Doripenem, Polymyxin B, and Rifampin against Multidrug-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli, Antimicrobial Agents and Chemotherapy, vol.54, issue.6, pp.2732-2734, 2010.
DOI : 10.1128/AAC.01768-09

E. B. Hirsch and V. H. Tam, Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection, Journal of Antimicrobial Chemotherapy, vol.65, issue.6, pp.1119-1125, 2010.
DOI : 10.1093/jac/dkq108

L. Mamelli, S. Petit, J. Chevalier, C. Giglione, A. Lieutaud et al., New Antibiotic Molecules: Bypassing the Membrane Barrier of Gram Negative Bacteria Increases the Activity of Peptide Deformylase Inhibitors, PLoS ONE, vol.3, issue.7, p.6443, 2009.
DOI : 10.1371/journal.pone.0006443.t005
URL : https://hal.archives-ouvertes.fr/hal-00853795

M. Vaara, J. Fox, G. Loidl, O. Siikanen, J. Apajalahti et al., Novel Polymyxin Derivatives Carrying Only Three Positive Charges Are Effective Antibacterial Agents, Antimicrobial Agents and Chemotherapy, vol.52, issue.9, pp.3229-3236, 2008.
DOI : 10.1128/AAC.00405-08
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2533495

A. O. Gill and R. A. Holley, Disruption of Escherichia coli, Listeria monocytogenes and Lactobacillus sakei cellular membranes by plant oil aromatics, International Journal of Food Microbiology, vol.108, issue.1, pp.1-9, 2006.
DOI : 10.1016/j.ijfoodmicro.2005.10.009

S. Hemaiswarya and M. Doble, Synergistic interaction of eugenol with antibiotics against Gram negative bacteria, Phytomedicine, vol.16, issue.11, pp.997-1005, 2009.
DOI : 10.1016/j.phymed.2009.04.006

S. Pournaras, A. Poulou, and A. Tsakris, Inhibitor-based methods for the detection of KPC carbapenemase-producing Enterobacteriaceae in Chemother, pp.1319-1321, 2010.

R. F. Epand, J. E. Pollard, J. O. Wright, P. B. Savage, and R. M. Epand, Depolarization, Bacterial Membrane Composition, and the Antimicrobial Action of Ceragenins, Antimicrobial Agents and Chemotherapy, vol.54, issue.9, pp.3708-3713, 2010.
DOI : 10.1128/AAC.00380-10

S. Saha, P. B. Savage, and M. Bal, Enhancement of the efficacy of erythromycin in multiple antibiotic-resistant gram-negative bacterial pathogens, Journal of Applied Microbiology, vol.47, issue.3, pp.822-828, 2008.
DOI : 10.1111/j.1365-2672.2008.03820.x

K. Leszczynska, A. Namiot, K. Cruz, F. J. Byfield, E. Won et al., Potential of ceragenin CSA-13 and its mixture with pluronic F-127 as treatment of topical bacterial infections, Journal of Applied Microbiology, vol.28, issue.1, pp.229-238, 2011.
DOI : 10.1111/j.1365-2672.2010.04874.x

C. Salmi, C. Loncle, N. Vidal, Y. Letourneux, J. Fantini et al., Squalamine: An Appropriate Strategy against the Emergence of Multidrug Resistant Gram-Negative Bacteria?, PLoS ONE, vol.90, issue.7, 2008.
DOI : 10.1371/journal.pone.0002765.t005
URL : https://hal.archives-ouvertes.fr/hal-00400776

K. Alhanout, S. Malesinki, N. Vidal, V. Peyrot, J. M. Rolain et al., New insights into the antibacterial mechanism of action of squalamine, Journal of Antimicrobial Chemotherapy, vol.65, issue.8, pp.1688-1693, 2010.
DOI : 10.1093/jac/dkq213
URL : https://hal.archives-ouvertes.fr/hal-01460197

J. P. Lavigne, J. M. Brunel, J. Chevalier, and J. Pagès, Squalamine, an original chemosensitizer to combat antibiotic-resistant Gram-negative bacteria, Journal of Antimicrobial Chemotherapy, vol.65, issue.4, pp.799-801, 2010.
DOI : 10.1093/jac/dkq031
URL : https://hal.archives-ouvertes.fr/inserm-00465656

M. Ouberai, F. Garch, A. Bussiere, M. Riou, D. Alsteens et al., The Pseudomonas aeruginosa membranes: A target for a new amphiphilic aminoglycoside derivative?, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1808, issue.6, pp.1716-1727, 2011.
DOI : 10.1016/j.bbamem.2011.01.014

R. M. Epand, R. F. Epand, and P. B. Savage, Ceragenins (Cationic Steroid Compounds), a novel class of antimicrobial agents, Drug News & Perspectives, vol.21, issue.6, pp.307-311, 2008.
DOI : 10.1358/dnp.2008.21.6.1246829

B. Findlay, G. G. Zhanel, and F. Schweizer, Cationic Amphiphiles, a New Generation of Antimicrobials Inspired by the Natural Antimicrobial Peptide Scaffold, Antimicrobial Agents and Chemotherapy, vol.54, issue.10, pp.4049-4058, 2010.
DOI : 10.1128/AAC.00530-10

H. Cao and X. Liu, Silver nanoparticles-modified films versus biomedical device-associated infections, Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, vol.8, issue.6, pp.670-684, 2010.
DOI : 10.1002/wnan.113

K. Chaloupka, Y. Malam, and A. M. Seifalian, Nanosilver as a new generation of nanoproduct in biomedical applications, Trends in Biotechnology, vol.28, issue.11, pp.580-588, 2010.
DOI : 10.1016/j.tibtech.2010.07.006

S. C. Abeylath and E. Turos, Drug delivery approaches to overcome bacterial resistance to ??-lactam antibiotics, Expert Opinion on Drug Delivery, vol.91, issue.9, pp.931-949, 2008.
DOI : 10.1038/nrmicro1557

D. Pissuwan, C. H. Cortie, S. M. Valenzuela, and M. B. Cortie, Functionalised gold nanoparticles for controlling pathogenic bacteria, Trends in Biotechnology, vol.28, issue.4, pp.207-213, 2010.
DOI : 10.1016/j.tibtech.2009.12.004

J. Pagès and L. Amaral, Mechanisms of drug efflux and strategies to combat them: Challenging the efflux pump of Gram-negative bacteria, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, vol.1794, issue.5, pp.826-833, 2009.
DOI : 10.1016/j.bbapap.2008.12.011

M. E. Falagas, A. P. Grammatikos, and A. Michalopoulos, Potential of old-generation antibiotics to address current need for new antibiotics, Expert Review of Anti-infective Therapy, vol.6, issue.5, pp.593-600, 2008.
DOI : 10.1586/14787210.6.5.593

M. R. Yeaman and N. Y. Yount, Mechanisms of Antimicrobial Peptide Action and Resistance, Pharmacological Reviews, vol.55, issue.1, pp.27-55, 2003.
DOI : 10.1124/pr.55.1.2

D. Drew, M. M. Klepsch, S. Newstead, R. Flaig, J. De-gier et al., The structure of the efflux pump AcrB in complex with bile acid, Molecular Membrane Biology, vol.368, issue.8, pp.677-682, 2008.
DOI : 10.1126/science.1083137

S. Murakami, R. Nakashima, E. Yamashita, and A. Yamaguchi, Crystal structure of bacterial multidrug efflux transporter AcrB, Nature, vol.11, issue.6907, pp.587-593, 2002.
DOI : 10.1107/S0021889891004399

E. W. Yu, G. Mcdermott, H. I. Zgurskaya, H. Nikaido, K. Jr et al., Structural Basis of Multiple Drug-Binding Capacity of the AcrB Multidrug Efflux Pump, Science, vol.300, issue.5621, pp.976-980, 2003.
DOI : 10.1126/science.1083137

E. W. Yu, J. R. Aires, G. Mcdermott, H. G. Nikaido, M. A. Bukowska et al., A Periplasmic Drug-Binding Site of the AcrB Multidrug Efflux Pump: a Crystallographic and Site-Directed Mutagenesis Study, Journal of Bacteriology, vol.187, issue.19, pp.6804-6815, 2005.
DOI : 10.1128/JB.187.19.6804-6815.2005

M. A. Seeger, K. Diederich, T. Eicher, L. Brandstätter, A. Schiefner et al., The AcrB Efflux Pump: Conformational Cycling and Peristalsis Lead to Multidrug Resistance, Current Drug Targets, vol.9, issue.9, pp.729-749, 2008.
DOI : 10.2174/138945008785747789

K. Nakayama, H. Kawato, J. Watanabe, M. Ohtsuka, K. Yoshida et al., MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 3: Optimization of potency in the pyridopyrimidine series through the application of a pharmacophore model, Bioorganic & Medicinal Chemistry Letters, vol.14, issue.2, pp.475-479, 2004.
DOI : 10.1016/j.bmcl.2003.10.060

T. E. Renau, R. Leger, E. M. Flamme, J. Sangalang, M. W. She et al., Potentiate the Activity of the Fluoroquinolone Antibacterial Levofloxacin, Journal of Medicinal Chemistry, vol.42, issue.24, pp.4928-4931, 1999.
DOI : 10.1021/jm9904598

O. Lomovskaya, H. I. Zgurskaya, M. Totrov, and W. J. Watkins, Waltzing transporters and 'the dance macabre' between humans and bacteria, Nature Reviews Drug Discovery, vol.43, issue.1, pp.56-65, 2007.
DOI : 10.1038/nrd2200

O. Lomovskaya, K. A. Bostian, R. Nakashima, E. Yamashita, T. Matsumoto et al., Practical applications and feasibility of efflux pump inhibitors in the clinic ? a vision for applied use clinical practice by using boronic acid compounds Crystal structures of a multidrug transporter reveal a functionally rotating mechanism, Biochem. Pharmacol. J. Antimicrob. Nature, vol.7176, issue.443, pp.910-918, 2006.

T. E. Renau, R. Leger, E. M. Flamme, M. W. She, C. L. Gannon et al., Addressing the stability of C-capped dipeptide efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa, Bioorganic & Medicinal Chemistry Letters, vol.11, issue.5, pp.663-667, 2001.
DOI : 10.1016/S0960-894X(01)00033-6

W. J. Watkins, Y. Landaverry, R. Léger, R. Litman, T. E. Renau et al., The relationship between physicochemical properties, In vitro activity and pharmacokinetic profiles of analogues of diamine-Containing efflux pump inhibitors, Bioorganic & Medicinal Chemistry Letters, vol.13, issue.23, pp.4241-4244, 2003.
DOI : 10.1016/j.bmcl.2003.07.030

J. Kriengkauykiat, E. Porter, O. Lomovskaya, and A. Wong-beringer, Use of an Efflux Pump Inhibitor To Determine the Prevalence of Efflux Pump-Mediated Fluoroquinolone Resistance and Multidrug Resistance in Pseudomonas aeruginosa, Antimicrobial Agents and Chemotherapy, vol.49, issue.2, pp.565-570, 2005.
DOI : 10.1128/AAC.49.2.565-570.2005

K. Yoshida, K. Nakayama, M. Ohtsuka, N. Kuru, Y. Yokomizo et al., MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 7: Highly soluble and in vivo active quaternary ammonium analogue D13-9001, a potential preclinical candidate, Bioorganic & Medicinal Chemistry, vol.15, issue.22, pp.7087-7097, 2007.
DOI : 10.1016/j.bmc.2007.07.039

A. Mahamoud, J. Chevalier, S. Alibert-franco, V. W. Kern, and J. Pagès, Antibiotic efflux pumps in Gram-negative bacteria: the inhibitor response strategy, Journal of Antimicrobial Chemotherapy, vol.59, issue.6, pp.1223-1229, 2007.
DOI : 10.1093/jac/dkl493
URL : https://hal.archives-ouvertes.fr/hal-01425047

A. Mahamoud, J. Chevalier, M. Baitiche, E. Adam, and J. Pagès, An alkylaminoquinazoline restores antibiotic activity in Gram-negative resistant isolates, Microbiology, vol.157, issue.2, pp.566-571, 2011.
DOI : 10.1099/mic.0.045716-0

C. Wehmeier, S. Schuster, E. Fähnrich, W. V. Kern, and J. A. Bohnert, Site-Directed Mutagenesis Reveals Amino Acid Residues in the Escherichia coli RND Efflux Pump AcrB That Confer Macrolide Resistance, Antimicrobial Agents and Chemotherapy, vol.53, issue.1, pp.329-330, 2009.
DOI : 10.1128/AAC.00921-08

J. A. Bohnert and W. V. Kern, Selected Arylpiperazines Are Capable of Reversing Multidrug Resistance in Escherichia coli Overexpressing RND Efflux Pumps, Antimicrobial Agents and Chemotherapy, vol.49, issue.2, pp.849-852, 2005.
DOI : 10.1128/AAC.49.2.849-852.2005

W. V. Kern, P. Steinke, A. Schumacher, S. Schuster, H. Von-baum et al., Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli, Journal of Antimicrobial Chemotherapy, vol.57, issue.2, pp.339-343, 2006.
DOI : 10.1093/jac/dki445

A. Schumacher, P. Steinke, J. A. Bohnert, M. Akova, D. Jonas et al., Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than Escherichia coli, Journal of Antimicrobial Chemotherapy, vol.57, issue.2, pp.344-348, 2006.
DOI : 10.1093/jac/dki446

S. Pannek, P. G. Higgins, P. Steinke, D. Jonas, M. Akova et al., Multidrug efflux inhibition in Acinetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-??-naphthylamide, Journal of Antimicrobial Chemotherapy, vol.57, issue.5, pp.970-974, 2006.
DOI : 10.1093/jac/dkl081
URL : http://jac.oxfordjournals.org/cgi/content/short/57/5/970

A. Schumacher, R. Trittler, J. A. Bohnert, K. Kümmerer, J. Pagès et al., Intracellular accumulation of linezolid in Escherichia coli, Citrobacter freundii and Enterobacter aerogenes: role of enhanced efflux pump activity and inactivation, Journal of Antimicrobial Chemotherapy, vol.59, issue.6, pp.1261-1264, 2007.
DOI : 10.1093/jac/dkl380

M. Hannula and M. L. Hänninen, Effect of putative efflux pump inhibitors and inducers on the antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coli, Journal of Medical Microbiology, vol.57, issue.7, pp.851-855, 2008.
DOI : 10.1099/jmm.0.47823-0

K. Kiec-kononowicz and E. Szymanska, Antimycobacterial Activity of 5-Arylidene Derivatives of Hydantoin., ChemInform, vol.57, issue.10, pp.909-916, 2002.
DOI : 10.1002/chin.200310129

E. Szymanska and K. Kiec-kononowicz, Antimycobacterial activity of 5-arylidene aromatic derivatives of hydantoin, Il Farmaco, vol.57, issue.5, pp.355-362, 2002.
DOI : 10.1016/S0014-827X(01)01194-6

K. Kiec-kononowicz, Synthesis and evaluation of in vivo activity of diphenylhydantoin basic derivatives, Eur. J. Med. Chem, vol.39, pp.1013-1026, 2004.

M. Martins, S. G. Dastidar, S. Fanning, J. E. Kristiansen, J. Molnar et al., Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities, International Journal of Antimicrobial Agents, vol.31, issue.3, pp.198-208, 2008.
DOI : 10.1016/j.ijantimicag.2007.10.025

A. M. Bailey, I. T. Paulsen, and L. J. Piddock, RamA Confers Multidrug Resistance in Salmonella enterica via Increased Expression of acrB, Which Is Inhibited by Chlorpromazine, Antimicrobial Agents and Chemotherapy, vol.52, issue.10, pp.3604-3611, 2008.
DOI : 10.1128/AAC.00661-08

L. Rodrigues, D. Wagner, M. Viveiros, D. Sampaio, I. Couto et al., Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis, Journal of Antimicrobial Chemotherapy, vol.61, issue.5, pp.1076-1082, 2008.
DOI : 10.1093/jac/dkn070

L. Amaral, M. Martins, M. Viveiros, J. Molnar, and J. E. Kristiansen, Promising Therapy of XDR-TB/MDR-TB with Thioridazine an Inhibitor of Bacterial Efflux Pumps, Current Drug Targets, vol.9, issue.9, pp.816-819, 2008.
DOI : 10.2174/138945008785747798

M. Viveiros, M. Martins, I. Couto, I. Rodrigues, G. Spengler et al., New Methods for the Identification of Efflux Mediated MDR Bacteria, Genetic Assessment of Regulators and Efflux Pump Constituents, Characterization of Efflux Systems and Screening for Inhibitors of Efflux Pumps, Current Drug Targets, vol.9, issue.9, pp.760-778, 2008.
DOI : 10.2174/138945008785747734

M. Stavri, L. J. Piddock, and S. Gibbons, Bacterial efflux pump inhibitors from natural sources, Journal of Antimicrobial Chemotherapy, vol.59, issue.6, pp.1247-1260, 2007.
DOI : 10.1093/jac/dkl460
URL : http://jac.oxfordjournals.org/cgi/content/short/59/6/1247

S. Gibbons, Phytochemicals for Bacterial Resistance - Strengths, Weaknesses and Opportunities, Planta Medica, vol.74, issue.6, pp.594-602, 2008.
DOI : 10.1055/s-2008-1074518

F. R. Stermitz, P. Lorenz, J. N. Tawara, L. A. Zenewicz, and K. Lewis, Synergy in a medicinal plant: Antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor, Proc. Natl. Acad, 2000.
DOI : 10.1073/pnas.030540597

K. Lewis and F. M. Ausubel, Prospects for plant-derived antibacterials, Nature Biotechnology, vol.103, issue.12, pp.1504-1507, 2006.
DOI : 10.1038/nbt1206-1504

H. D. Coutinho, J. G. Costa, E. O. Lima, V. S. Falcão-silva, and J. P. Siqueira-júnior, Enhancement of the Antibiotic Activity against a Multiresistant <i>Escherichia coli</i> by <i>Mentha arvensis </i>L. and Chlorpromazine, Chemotherapy, vol.54, issue.4, pp.328-330, 2008.
DOI : 10.1159/000151267

H. D. Coutinho, J. G. Costa, E. O. Lima, V. S. Falcao-silva, and J. P. Siqueira-junior, Increasing of the Aminoglicosyde Antibiotic Activity Against a Multidrug-Resistant E. coli by Turnera ulmifolia L. and Chlorpromazine, Biological Research For Nursing, vol.11, issue.4, pp.332-335, 2010.
DOI : 10.1177/1099800409340052

S. Shin, Anti-Salmonella activity of lemongrass oil alone and in combination with antibiotics, Nat. Prod. Sci, vol.11, pp.160-164, 2005.

N. Thota, S. Koul, M. V. Reddy, P. L. Sangwan, I. A. Khan et al., Citral derived amides as potent bacterial NorA efflux pump inhibitors, Bioorganic & Medicinal Chemistry, vol.16, issue.13, pp.6535-6543, 2008.
DOI : 10.1016/j.bmc.2008.05.030

P. Natarajan, S. Katta, I. Andrei, V. Babu-rao-ambati, M. Leonida et al., Positive antibacterial co-action between hop (Humulus lupulus) constituents and selected antibiotics, Phytomedicine, vol.15, issue.3, pp.194-201, 2008.
DOI : 10.1016/j.phymed.2007.10.008

V. Lorenzi, A. Muselli, A. F. Bernardini, L. Berti, J. Pagès et al., Geraniol restores antibiotic activities against, 2009.
DOI : 10.1128/aac.00919-08
URL : https://hal.archives-ouvertes.fr/hal-01148473

T. Dyla-?-g, M. Zygmunt, D. Macia-?-g, J. Handzlik, and M. Bednarski, Filipek, B. and resistant isolates from gram-negative species, Antimicrob. Agents Chemother, vol.53, pp.2209-2211

L. Amaral, J. Pagès, and S. Fanning, Efflux Pumps of Gram-Negative Bacteria: Genetic Responses to Stress and the Modulation of their Activity by pH, Inhibitors, and Phenothiazines, Adv. Enzymol. Relat. Areas Mol. Biol, vol.185, issue.11, pp.61-108, 2011.
DOI : 10.1002/9780470920541.ch2